A recent study published in the British Medical Journal has revealed promising news regarding the effectiveness of COVID-19 vaccines in reducing the risk of heart failure and blood clots after a COVID infection. The study, which looked at over 20 million people in Europe, found that vaccines such as Moderna, Pfizer, AstraZeneca, and Johnson & Johnson could cut the risk of heart failure by up to 55% and blood clots by up to 78%.
Dr. John Brownstein, chief innovation officer at Boston Children’s Hospital, emphasized that the positive health effects of the vaccines were more pronounced immediately after vaccination and could last for up to a year. He also noted that the risk of complications is higher when the infection comes from the SARS-CoV-2 virus itself.
The research took into account both the original strain of the virus and the Delta variant, and the results showed a significant reduction in the risk of blood clots in veins, blood clots in arteries, and heart failure within a month of vaccination. Over a six-month period, the risk of these complications was still significantly reduced.
In light of these findings, the U.S. Centers for Disease Control and Prevention (CDC) has authorized an updated COVID-19 vaccine for adults over 65 to further protect against severe hospitalization and death. These results underscore the importance of COVID-19 vaccines as essential tools in reducing the risk of long-term health issues following infection. Stay informed and stay safe with Poh Diaries.
“Zombie enthusiast. Subtly charming travel practitioner. Webaholic. Internet expert.”